The TLR9 ligand, CpG-ODN, induces protection against cerebral ischemia/reperfusion injury via activation of PI3K/Akt signaling.

The TLR9 ligand, CpG-ODN, induces protection against cerebral ischemia/reperfusion injury via activation of PI3K/Akt signaling.

Item
http://www.wikidata.org/entity/Q34297287
Poly (I:C) therapy decreases cerebral ischaemia/reperfusion injury via TLR3-mediated prevention of Fas/FADD interactionFunction and mechanism of toll-like receptors in cerebral ischemic tolerance: from preconditioning to treatment.Protective effects of monosialotetrahexosylganglioside sodium on H2O2-induced human vascular endothelial cells.Toll-like Receptors in the Vascular System: Sensing the Dangers Within.Intravenous high mobility group box 1 upregulates the expression of HIF-1α in the myocardium via a protein kinase B-dependent pathway in rats following acute myocardial ischemia.The protective effects of shikonin on hepatic ischemia/reperfusion injury are mediated by the activation of the PI3K/Akt pathway.Potential medications or compounds acting on toll-like receptors in cerebral ischemia.Preclinical Development of a Prophylactic Neuroprotective Therapy for the Preventive Treatment of Anticipated Ischemia-Reperfusion Injury.CpG oligodeoxynucleotide preconditioning improves cardiac function after myocardial infarction via modulation of energy metabolism and angiogenesis.Neuroprotective effects of rhynchophylline against ischemic brain injury via regulation of the Akt/mTOR and TLRs signaling pathways.Salvianolic Acid B Ameliorates Cerebral Ischemia/Reperfusion Injury Through Inhibiting TLR4/MyD88 Signaling Pathway.Xingnaojing Injection Protects against Cerebral Ischemia Reperfusion Injury via PI3K/Akt-Mediated eNOS PhosphorylationSC79, the AKT Activator Protects Cerebral Ischemia in a Rat Model of Ischemia/Reperfusion Injury
P2860

The TLR9 ligand, CpG-ODN, induces protection against cerebral ischemia/reperfusion injury via activation of PI3K/Akt signaling.

Item
http://www.wikidata.org/entity/Q34297287
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The TLR9 ligand, CpG-ODN, indu ...... ivation of PI3K/Akt signaling.
@ast
The TLR9 ligand, CpG-ODN, indu ...... ivation of PI3K/Akt signaling.
@en
The TLR9 ligand, CpG-ODN, indu ...... ivation of PI3K/Akt signaling.
@nl
type
label
The TLR9 ligand, CpG-ODN, indu ...... ivation of PI3K/Akt signaling.
@ast
The TLR9 ligand, CpG-ODN, indu ...... ivation of PI3K/Akt signaling.
@en
The TLR9 ligand, CpG-ODN, indu ...... ivation of PI3K/Akt signaling.
@nl
prefLabel
The TLR9 ligand, CpG-ODN, indu ...... ivation of PI3K/Akt signaling.
@ast
The TLR9 ligand, CpG-ODN, indu ...... ivation of PI3K/Akt signaling.
@en
The TLR9 ligand, CpG-ODN, indu ...... ivation of PI3K/Akt signaling.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
The TLR9 ligand, CpG-ODN, indu ...... ivation of PI3K/Akt signaling.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932